» Articles » PMID: 9422841

Results of Electrophysiologic Studies in Patients with Acute Chagasic Myocarditis

Overview
Journal Clin Cardiol
Date 1998 Jan 10
PMID 9422841
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: As the acute stage of Chagas' myocarditis is rarely detected, little is known about the electrophysiologic characteristics of that stage.

Hypothesis: This investigation was undertaken to conduct an electrophysiologic study of the properties of the heart during the acute phase of Chagasic myocarditis.

Methods: We studied eight patients who had positive xenodiagnosis, positive mice culture, and positive complement fixation test for Chagas' disease.

Results: Trypanosoma cruzi were identified in all of the patients' stained blood samples. Right ventricular endomyocardial biopsies were obtained, evidencing a distinct infiltrate of lymphocytes that confirmed the diagnosis of acute myocarditis. The cardiac dimensions and the ventricular systolic and diastolic function were preserved in all patients. The electrocardiogram evidenced conduction defects in two patients. The signal-averaged electrocardiogram displayed late potentials in three patients. In the electrophysiologic study, atrial fibrillation or flutter was induced in four patients. When compared with control patients, Chagasic patients were found to have greater values of atrial threshold, A-H interval, and atrioventricular (AV) nodal effective refractory period. The H-V interval was mildly prolonged in two patients, but the dynamic AV nodal conduction was preserved (1:1 conduction during right atrial stimulation at a cycle length of 400 ms) in all the Chagasic patients. The ventricular parameters were within normal limits, and no sustained ventricular arrhythmia could be induced.

Conclusions: Patients with mild acute Chagasic myocarditis may suffer from electrical abnormalities and arrhythmias that are more evident at the supraventricular level and the AV junction.

Citing Articles

Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology.

Dobrev D, Heijman J, Hiram R, Li N, Nattel S Nat Rev Cardiol. 2022; 20(3):145-167.

PMID: 36109633 PMC: 9477170. DOI: 10.1038/s41569-022-00759-w.


Clinical evaluation of myocardial involvement in acute myopericarditis in young adults.

Saricam E, Saglam Y, Hazirolan T BMC Cardiovasc Disord. 2017; 17(1):129.

PMID: 28532506 PMC: 5440907. DOI: 10.1186/s12872-017-0564-8.


EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication.

Goette A, Kalman J, Aguinaga L, Akar J, Cabrera J, Chen S J Arrhythm. 2016; 32(4):247-78.

PMID: 27588148 PMC: 4996910. DOI: 10.1016/j.joa.2016.05.002.


EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication.

Goette A, Kalman J, Aguinaga L, Akar J, Cabrera J, Chen S Europace. 2016; 18(10):1455-1490.

PMID: 27402624 PMC: 6392440. DOI: 10.1093/europace/euw161.


EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.

Goette A, Kalman J, Aguinaga L, Akar J, Cabrera J, Chen S Heart Rhythm. 2016; 14(1):e3-e40.

PMID: 27320515 PMC: 5548137. DOI: 10.1016/j.hrthm.2016.05.028.

References
1.
Prystowsky E . Electrophysiologic-electropharmacologic testing in patients with ventricular arrhythmias. Pacing Clin Electrophysiol. 1988; 11(2):225-51. DOI: 10.1111/j.1540-8159.1988.tb04545.x. View

2.
Sousa A, Marin-Neto J, Maciel B, Gallo Jr L, Amorim D . Cardiac parasympathetic impairment in gastrointestinal Chagas' disease. Lancet. 1987; 1(8539):985. DOI: 10.1016/s0140-6736(87)90340-0. View

3.
Espinosa R, Carrasco H, Belandria F, FUENMAYOR A, Molina C, Gonzalez R . Life expectancy analysis in patients with Chagas' disease: prognosis after one decade (1973-1983). Int J Cardiol. 1985; 8(1):45-56. DOI: 10.1016/0167-5273(85)90262-1. View

4.
Andrade Z, Miziara H . [Changes in the genesis and heart conduction systems in the acute phase of human Chagas' disease]. Arq Bras Cardiol. 1983; 40(4):233-7. View

5.
Rossi M, Bestetti R . The challenge of chagasic cardiomyopathy. The pathologic roles of autonomic abnormalities, autoimmune mechanisms and microvascular changes, and therapeutic implications. Cardiology. 1995; 86(1):1-7. DOI: 10.1159/000176822. View